Atenolol
- Product NDC
- 65862-169
- 11-digit product format
- 658620169
- Labeler code
- 65862
- Product ID
- 65862-169_c5b37783-b0a1-4d21-b0cc-69a13cc4d2db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA078512
- Marketing category
- ANDA
- Marketing start
- 2007-10-31
- Substance
- ATENOLOL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atenolol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ATENOLOL | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 50VV3VW0TI |
| Rxcui | 197379, 197380, 197381 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65862-169-01 | Atenolol | 100 in 1 BOTTLE | TABLET | 100 | | 13 |
| 65862-169-99 | Atenolol | 1000 in 1 BOTTLE | TABLET | 1000 | | 13 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ATENOLOL | ACTIVE INGREDIENT | 50VV3VW0TI | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 7 | |
| ATENOLOL | ACTIVE MOIETY | 50VV3VW0TI | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 7 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 7 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 7 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 7 | |
| POVIDONE K90 | INACTIVE INGREDIENT | RDH86HJV5Z | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 7 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 7 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 7 | |
| ATENOLOL | ACTIVE INGREDIENT | 50VV3VW0TI | ATENOLOL TABLET [MED-HEALTH PHARMA, LLC] | 3 | |
| ATENOLOL | ACTIVE INGREDIENT | 50VV3VW0TI | ATENOLOL TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 3 | |
| ATENOLOL | ACTIVE MOIETY | 50VV3VW0TI | ATENOLOL TABLET [MED-HEALTH PHARMA, LLC] | 3 | |
| ATENOLOL | ACTIVE MOIETY | 50VV3VW0TI | ATENOLOL TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ATENOLOL TABLET [MED-HEALTH PHARMA, LLC] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ATENOLOL TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 3 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ATENOLOL TABLET [MED-HEALTH PHARMA, LLC] | 3 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | ATENOLOL TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ATENOLOL TABLET [MED-HEALTH PHARMA, LLC] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ATENOLOL TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 3 | |
| POVIDONE K90 | INACTIVE INGREDIENT | RDH86HJV5Z | ATENOLOL TABLET [MED-HEALTH PHARMA, LLC] | 3 | |
| POVIDONE K90 | INACTIVE INGREDIENT | RDH86HJV5Z | ATENOLOL TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ATENOLOL TABLET [MED-HEALTH PHARMA, LLC] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ATENOLOL TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 3 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | ATENOLOL TABLET [MED-HEALTH PHARMA, LLC] | 3 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | ATENOLOL TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65862-169 | ATENOLOL TABLET [AUROBINDO PHARMA LIMITED] | 13 | Current NDC, Legacy NDC, 2 package rows | 20240224_1b8a4689-3916-4f4b-b54a-bbb4e322d79b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65862-169-01 | 65862016901 | 100 TABLET in 1 BOTTLE (65862-169-01) | 100 tablet | 2007-10-31 | 0000-00-00 | No | No | Current |
| 65862-169-99 | 65862016999 | 1000 TABLET in 1 BOTTLE (65862-169-99) | 1000 tablet | 2007-10-31 | 0000-00-00 | No | No | Current |